Safety trials are underway for a Cambridge-led vaccine that could be used as a booster targeting COVID-19 virus variants and relatives that threaten future coronavirus pandemics. The first volunteer is expected to receive the vaccine today at the NIHR Southampton Clinical Research Facility.…
Read More »
The FINANCIAL -- A new large-scale study shows that a quarter of the UK…
Safety trials are underway for a Cambridge-led vaccine that could be used as a booster targeting COVID-19 virus variants and relatives that threaten future coronavirus pandemics. The first volunteer is expected to receive the vaccine today at the NIHR Southampton Clinical Research Facility.…
The FINANCIAL -- A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia, University of Oxford notes.…
